Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 4—April 2018
Research

Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010–2016

Charlene M.C. RodriguesComments to Author , Jay Lucidarme, Ray Borrow, Andrew Smith, J. Claire Cameron, E. Richard Moxon, and Martin C.J. Maiden
Author affiliations: University of Oxford, Oxford, UK (C.M.C. Rodrigues, E.R. Moxon, M.C.J. Maiden); Public Health England, Manchester, UK (J. Lucidarme, R. Borrow); Glasgow Royal Infirmary, Glasgow, Scotland, UK (A. Smith); University of Glasgow, Glasgow (A. Smith); Health Protection Scotland, Glasgow (J.C. Cameron)

Main Article

Table 1

Geographic distribution of culture-confirmed invasive meningococcal disease isolates that have undergone whole- genome sequencing, United Kingdom, 2010–2016*

1 2 3 4 Total PHE PHS A B C E NG W W/Y X Y Z
2010−11 464 37 36 13 550 1,009 (46.0) 76 (47.4) 1 423 13 1 5 27 2 1 76 1
2011−12 370 28 30 11 439 730 (50.7) 56 (53.6) 0 311 18 1 4 32 1 0 72 0
2012−13 415 29 34 13 491 769 (54.0) 66 (51.5) 0 325 29 0 7 51 1 0 78 0
2013−14 367 27 30 12 436 636 (57.7) 60 (50.0) 0 240 24 0 1 92 2 0 77 0
2014−15 483 19 55 15 572 724 (66.7) 65 (84.6) 0 283 23 0 5 172 2 0 87 0
2015−16
488
23
62
12
585

805 (60.6)
99 (62.6)

0
238
34
2
8
197
2
0
104
0
Total
2,587
163
247
76
3,073

4,673 (55.4)
442 (55.9)

1
1,820
141
4
30
571
10
1
494
1
*Laboratory-confirmed cases included culture-confirmed and PCR-confirmed cases. Data included in this study represented 55.4% of all laboratory-confirmed cases in England and 55.9% of those in Scotland. NG, nongroupable; PHE, Public Health England; PHS, Public Health Scotland.
†1, England; 2, Wales; 3, Scotland; 4, Northern Ireland.
‡W/Y serogroups were combined because of inconclusive serogrouping results.

Main Article

Page created: March 19, 2018
Page updated: March 19, 2018
Page reviewed: March 19, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external